Search website

If you cannot find, what you are looking for, try searching for it below or visit our FAQ-page.

Close
News & Events »
Tillotts Pharma AG announces a new sales organisation for its products in Switzerland

Press Release

Tillotts Pharma AG announces a new sales organisation for its products in Switzerland

The new establishment is part of Tillotts ambitious expansion plans throughout Europe [...] Read more »
Tillotts Pharma AG continues growth with launch in Belgium, the Netherlands and Luxembourg

Press Release

Tillotts Pharma AG continues growth with launch in Belgium, the Netherlands and Luxembourg

Tillotts Pharma AG strengthens its network in Europe by entering in Benelux market, wh[...] Read more »
Tillotts Pharma AG announces launch of Asacol<sup>TM</sup> 1G suppositories for treatment of ulcerative proctitis

Press Release

Tillotts Pharma AG announces launch of AsacolTM 1G suppositories for treatment of ulcerative proctitis

This new medication supports Tillotts strong gastroenterology portfolio and further st[...] Read more »
Tillotts Pharma AG under Agreement to Acquire Rights for DIFICLIR<sup>TM</sup> (fidaxomicin) from Astellas Pharma Europe Ltd.

Press Release

Tillotts Pharma AG under Agreement to Acquire Rights for DIFICLIRTM (fidaxomicin) from Astellas Pharma Europe Ltd.

Tillotts Pharma AG has acquired the rights to DIFICLIRTM (fidaxomicin) from Astellas P[...] Read more »
Tillotts and Menarini Receive Regulatory Approval for Asacol® 400 and 800 mg Tablets in the People’s Republic of China

Press Release

Tillotts and Menarini Receive Regulatory Approval for Asacol® 400 and 800 mg Tablets in the People’s Republic of China

RHEINFELDEN, Switzerland, June 4th, 2020 – Tillotts Pharma AG (“Tillotts”), part of [...] Read more »
Tillotts Pharma AG is One of the Best Employers in Switzerland

Press Release

Tillotts Pharma AG is One of the Best Employers in Switzerland

RHEINFELDEN, Switzerland, 13 May 2020 – Tillotts Pharma AG (Tillotts), a fast-growing sp[...] Read more »
1 2 3 4 8